Cargando…

The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases

The autophagy‐lysosomal pathway (ALP) is involved in the degradation of protein aggregates and damaged organelles. Transcription factor EB (TFEB), a major regulator of ALP, has emerged as a leading factor in addressing neurodegenerative disease pathology, including Alzheimer's disease (AD), Par...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Fengjuan, Zhou, Bojie, Meng, Lingyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804079/ https://www.ncbi.nlm.nih.gov/pubmed/36184826 http://dx.doi.org/10.1111/cns.13985

Ejemplares similares

The Role and Regulatory Mechanism of Transcription Factor EB in Health and Diseases
por: Zhu, Sheng-yu, et al.
Publicado: (2021)

Transcription factor EB regulates cardiovascular homeostasis
por: Lu, Haocheng, et al.
Publicado: (2021)

Therapeutic Potential of Vital Transcription Factors in Alzheimer’s and Parkinson’s Disease With Particular Emphasis on Transcription Factor EB Mediated Autophagy
por: Rai, Sachchida Nand, et al.
Publicado: (2021)

Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease
por: Spampanato, Carmine, et al.
Publicado: (2013)

The post‐translational regulation of transcription factor EB (TFEB) in health and disease
por: Takla, Michael, et al.
Publicado: (2023)

The phytochemical and pharmacological profile of taraxasterol
por: Jiao, Fengjuan, et al.
Publicado: (2022)

The Transcription Factor EB Links Cellular Stress to the Immune Response  
por: Nabar, Neel R., et al.
Publicado: (2017)

Novel Insight into Functions of Transcription Factor EB (TFEB) in Alzheimer’s Disease and Parkinson’s Disease
por: Yang, Jing, et al.
Publicado: (2023)

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
por: Gao, Chao, et al.
Publicado: (2023)

Transcription factor EB coordinates environmental cues to regulate T regulatory cells’ mitochondrial fitness and function
por: Xia, Minghui, et al.
Publicado: (2022)

Multifaceted activities of transcription factor EB in cancer onset and progression
por: Astanina, Elena, et al.
Publicado: (2020)

Transcription factor EB as a key molecular factor in human health and its implication in diseases
por: Gebrie, Alemu
Publicado: (2023)

The bHLH Transcription Factors in Neural Development and Therapeutic Applications for Neurodegenerative Diseases
por: Lee, Dong Gi, et al.
Publicado: (2022)

Multiple Mechanisms Converging on Transcription Factor EB Activation by the Natural Phenol Pterostilbene
por: La Spina, Martina, et al.
Publicado: (2021)

The Oncogene Transcription Factor EB Regulates Vascular Functions
por: Doronzo, Gabriella, et al.
Publicado: (2021)

Targeting Emerging Pathogenic Mechanisms by Natural Molecules as Potential Therapeutics for Neurodegenerative Diseases
por: Dou, Yan, et al.
Publicado: (2022)

Therapeutic Potential and Molecular Mechanisms of Echinacoside in Neurodegenerative Diseases
por: Li, Jin, et al.
Publicado: (2022)

A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer
por: Wang, Ting, et al.
Publicado: (2023)

Underlying Mechanisms of Brain Aging and Neurodegenerative Diseases as Potential Targets for Preventive or Therapeutic Strategies Using Phytochemicals
por: Abdolmaleky, Hamid Mostafavi, et al.
Publicado: (2023)

Transcription Factor EB Controls Metabolic Flexibility during Exercise
por: Mansueto, Gelsomina, et al.
Publicado: (2017)

Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies
por: Arotcarena, Marie-Laure, et al.
Publicado: (2019)

Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases
por: Bharadwaj, P R, et al.
Publicado: (2013)

Transcription factor EB agonists from natural products for treating human diseases with impaired autophagy-lysosome pathway
por: Xu, Jie, et al.
Publicado: (2020)

Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches
por: Hussain, Rashad, et al.
Publicado: (2018)

Necroptosis in neurodegenerative diseases: a potential therapeutic target
por: Zhang, Shuo, et al.
Publicado: (2017)

Therapeutic Potential of α-Crystallins in Retinal Neurodegenerative Diseases
por: Phadte, Ashutosh S., et al.
Publicado: (2021)

Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenues
por: Samudra, Niyatee, et al.
Publicado: (2023)

Protein-Remodeling Factors As Potential Therapeutics for Neurodegenerative Disease
por: Jackrel, Meredith E., et al.
Publicado: (2017)

Potentiation of rifampin activity in a mouse model of tuberculosis by activation of host transcription factor EB
por: Bryk, Ruslana, et al.
Publicado: (2020)

Fenamates as Potential Therapeutics for Neurodegenerative Disorders
por: Hill, Jaunetta, et al.
Publicado: (2021)

Oxidative Stress in Neurodegenerative Diseases: Mechanisms and Therapeutic Perspectives
por: Melo, Ailton, et al.
Publicado: (2011)

Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases
por: Ma, Ya-Min, et al.
Publicado: (2023)

The Implication of Reticulons (RTNs) in Neurodegenerative Diseases: From Molecular Mechanisms to Potential Diagnostic and Therapeutic Approaches
por: Kulczyńska-Przybik, Agnieszka, et al.
Publicado: (2021)

δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities
por: Zhang, Zhentao, et al.
Publicado: (2020)

Potential Role of Sirtuin as a Therapeutic Target for Neurodegenerative Diseases
por: Han, Seol-Heui
Publicado: (2009)

Therapeutic potential of systemic brain rejuvenation strategies for neurodegenerative disease
por: Horowitz, Alana M., et al.
Publicado: (2017)

Insights into the Therapeutic Potential of Glucocorticoid Receptor Modulators for Neurodegenerative Diseases
por: De Nicola, Alejandro F., et al.
Publicado: (2020)

Fatty Acids: An Insight into the Pathogenesis of Neurodegenerative Diseases and Therapeutic Potential
por: Vesga-Jiménez, Diego Julián, et al.
Publicado: (2022)

Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases
por: Khalaf, Kareem, et al.
Publicado: (2022)

Intracellular Trafficking and Persistence of Acinetobacter baumannii Requires Transcription Factor EB
por: Parra-Millán, Raquel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o0inin5tk3fiblq79m2tjpke76